Microtubule Inhibitor drugs compared

Compare all 4 Microtubule Inhibitor drugs side by side, used for conditions such as breast neoplasms, liposarcoma, carcinoma, non-small-cell lung. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is halaven.

2 of 4 drugs in this class carry a pharmaranks safety score, ranging 70–70 out of 100 — computed from FDA recall records, not from reviews.

Rated against independent sources·Last updated July 30, 2026·How we rate

Top-rated microtubule inhibitor: 1. Halaven · 2. Taxotere · 3. Docivyx

Microtubule Inhibitor drugs compared side by side, with pharmaranks' FDA recall-safety rating
Drug	Generic	Form	Status	Used for	Safety ratingFDA recall-based	Pharmacy pays
Halaven	Eribulin Mesylate	Injectable	Prescription	Breast Neoplasms, Liposarcoma	70/100	—
Taxotere	Docetaxel	Injectable	Prescription	Breast Neoplasms, Carcinoma, Non-Small-Cell Lung	70/100	—
Docivyx	Docetaxel	Injectable	Prescription	Breast Neoplasms, Carcinoma, Non-Small-Cell Lung	Not yet rated	—
Eribulin Mesylate	—	Injectable	Prescription	Breast Neoplasms, Liposarcoma	Not yet rated	—

The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.

Best microtubule inhibitor by condition

for breast neoplasms for liposarcoma for non-small-cell lung carcinoma for head and neck neoplasms for melanoma for ovarian neoplasms

Full ranking · 4 drugs

Frequently asked questions

What is the Microtubule Inhibitor drug class?

Microtubule Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 4 Microtubule Inhibitor products, each independently rated.

Are all Microtubule Inhibitor drugs the same?

No. Microtubule Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do Microtubule Inhibitor drugs treat?

Per NIH RxClass drug-classification data, Microtubule Inhibitor drugs are used for conditions including breast neoplasms, liposarcoma, carcinoma, non-small-cell lung, head and neck neoplasms, melanoma, ovarian neoplasms.

Which Microtubule Inhibitor drug is best-rated?

By our independent rating, halaven currently ranks highest among Microtubule Inhibitor drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.

Sources: the Microtubule Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.